Sfoglia per AUTORE
LEONI P
Collezione AO Ordine Mauriziano

  

Items : 3

The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia. in Oncotarget / Oncotarget. 2017 Sep 30;8(50):88021-88033. doi: 10.18632/oncotarget.21406. eCollection 2017 Oct 20.

2017
AO Ordine Mauriziano

Galimberti S; Bucelli C; Arrigoni E; Baratè C; Grassi S; Ricci F; Guerrini F; Ciabatti E; Fava C; D'Avolio A; Fontanelli G; Cambrin GR; Isidori A; Loscocco F; Caocci G; Greco M; Bocchia M; Aprile L; Gozzini A; Scappini B; Cattaneo D; Scortechini AR; La Nasa G; Bosi A; Leoni P; Danesi R; Saglio G; Visani G; Cortelezzi A; et alii...

The lymphocytes to monocytes ratio identifies a patient subgroup among high risk DLBCL that may benefit from upfront intensive treatment with autograft in Haematologica

2013
AO Ordine Mauriziano

Barbui AM; Masciulli A; Scarano M; Delaini F; Rossi A; Ladetto M; Corradini P; Di Nicola M; Patty C; Mulè A; Zanni M; Zoli V; Billio A; Gallamini A; Di Raimondo F; Ferreri AJM; Benedetti F; Leoni P; Semenzato G; Frezzato M; Flenghi L; Marchioli R; Barbui T; Gianni AM; Tarella C; Cortelazzo S; Rambaldi A;

High response rate with favorable survival projections in high-risk patients with diffuse large B-cell lymphoma (DLBCL) receiving R-CHOP-14 or early intensified chemotherapy with rituximab and autograft (R-HDS): Results of the interim analysis of a gitil prospective multicenter phase III study in Blood

2009
AO Ordine Mauriziano

Cortelazzo S; Tarella C; Gianni AM; Ladetto M; Zanni M; Corradini P; Di Nicola M; Patti C; Mulè A; Majolino I; Billio A; Gueli A; Di Raimondo F; Chiarenza A; Gallamini A; Ferreri A; Pizzolo G; Benedetti F; La Nasa G; Leoni P; Gini G; Trentin L; Rodeghiero F; Marchioli R; Barbui T; Barbui A; Rambaldi A;